Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5

Sylvia N. Kłodzińska, Daniel Pletzer, Negin Rahanjam, Thomas Rades, Robert Hancock, Hanne M. Nielsen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Anti-biofilm peptides are a subset of antimicrobial peptides and represent promising broad-spectrum agents for the treatment of bacterial biofilms, though some display host toxicity in vivo. Here we evaluated nanogels composed of modified hyaluronic acid for the encapsulation of the anti-biofilm peptide DJK-5 in vivo. Nanogels of 174 to 194 nm encapsulating 33–60% of peptide were created. Efficacy and toxicity of the nanogels were tested in vivo employing a murine abscess model of a Pseudomonas aeruginosa LESB58 high bacterial density infection. The dose of DJK-5 that could be administered intravenously to mice without inducing toxicity was more than doubled after encapsulation in nanogels. Upon subcutaneous administration, the toxicity of the DJK-5 in nanogels was decreased four-fold compared to non-formulated peptide, without compromising the anti-abscess effect of DJK-5. These findings support the use of nanogels to increase the safety of antimicrobial and anti-biofilm peptides after intravenous and subcutaneous administration.

LanguageEnglish
Article number102022
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume20
DOIs
Publication statusPublished - 1 Aug 2019

Keywords

  • Biofilm
  • Cationic peptide
  • Drug delivery
  • Nanogel
  • Pseudomonas aeruginosa

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Kłodzińska, Sylvia N. ; Pletzer, Daniel ; Rahanjam, Negin ; Rades, Thomas ; Hancock, Robert ; Nielsen, Hanne M. / Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2019 ; Vol. 20.
@article{1c7f509c4935417c9c4b879f6ba976af,
title = "Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5",
abstract = "Anti-biofilm peptides are a subset of antimicrobial peptides and represent promising broad-spectrum agents for the treatment of bacterial biofilms, though some display host toxicity in vivo. Here we evaluated nanogels composed of modified hyaluronic acid for the encapsulation of the anti-biofilm peptide DJK-5 in vivo. Nanogels of 174 to 194 nm encapsulating 33–60{\%} of peptide were created. Efficacy and toxicity of the nanogels were tested in vivo employing a murine abscess model of a Pseudomonas aeruginosa LESB58 high bacterial density infection. The dose of DJK-5 that could be administered intravenously to mice without inducing toxicity was more than doubled after encapsulation in nanogels. Upon subcutaneous administration, the toxicity of the DJK-5 in nanogels was decreased four-fold compared to non-formulated peptide, without compromising the anti-abscess effect of DJK-5. These findings support the use of nanogels to increase the safety of antimicrobial and anti-biofilm peptides after intravenous and subcutaneous administration.",
keywords = "Biofilm, Cationic peptide, Drug delivery, Nanogel, Pseudomonas aeruginosa",
author = "Kłodzińska, {Sylvia N.} and Daniel Pletzer and Negin Rahanjam and Thomas Rades and Robert Hancock and Nielsen, {Hanne M.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.nano.2019.102022",
language = "English",
volume = "20",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",

}

Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5. / Kłodzińska, Sylvia N.; Pletzer, Daniel; Rahanjam, Negin; Rades, Thomas; Hancock, Robert; Nielsen, Hanne M.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 20, 102022, 01.08.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5

AU - Kłodzińska, Sylvia N.

AU - Pletzer, Daniel

AU - Rahanjam, Negin

AU - Rades, Thomas

AU - Hancock, Robert

AU - Nielsen, Hanne M.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Anti-biofilm peptides are a subset of antimicrobial peptides and represent promising broad-spectrum agents for the treatment of bacterial biofilms, though some display host toxicity in vivo. Here we evaluated nanogels composed of modified hyaluronic acid for the encapsulation of the anti-biofilm peptide DJK-5 in vivo. Nanogels of 174 to 194 nm encapsulating 33–60% of peptide were created. Efficacy and toxicity of the nanogels were tested in vivo employing a murine abscess model of a Pseudomonas aeruginosa LESB58 high bacterial density infection. The dose of DJK-5 that could be administered intravenously to mice without inducing toxicity was more than doubled after encapsulation in nanogels. Upon subcutaneous administration, the toxicity of the DJK-5 in nanogels was decreased four-fold compared to non-formulated peptide, without compromising the anti-abscess effect of DJK-5. These findings support the use of nanogels to increase the safety of antimicrobial and anti-biofilm peptides after intravenous and subcutaneous administration.

AB - Anti-biofilm peptides are a subset of antimicrobial peptides and represent promising broad-spectrum agents for the treatment of bacterial biofilms, though some display host toxicity in vivo. Here we evaluated nanogels composed of modified hyaluronic acid for the encapsulation of the anti-biofilm peptide DJK-5 in vivo. Nanogels of 174 to 194 nm encapsulating 33–60% of peptide were created. Efficacy and toxicity of the nanogels were tested in vivo employing a murine abscess model of a Pseudomonas aeruginosa LESB58 high bacterial density infection. The dose of DJK-5 that could be administered intravenously to mice without inducing toxicity was more than doubled after encapsulation in nanogels. Upon subcutaneous administration, the toxicity of the DJK-5 in nanogels was decreased four-fold compared to non-formulated peptide, without compromising the anti-abscess effect of DJK-5. These findings support the use of nanogels to increase the safety of antimicrobial and anti-biofilm peptides after intravenous and subcutaneous administration.

KW - Biofilm

KW - Cationic peptide

KW - Drug delivery

KW - Nanogel

KW - Pseudomonas aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=85068142260&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2019.102022

DO - 10.1016/j.nano.2019.102022

M3 - Article

VL - 20

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

T2 - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

M1 - 102022

ER -